This trial is active, not recruiting.

Condition myopia
Sponsor University of Aarhus
Start date February 2011
End date October 2014
Trial size 125 participants
Trial identifier NCT01481792, AUH-Ophthalmology-2011-01


Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

time frame: Refraction one year after surgery
time frame: One year after surgery

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - Indication for keratorefractive correction of myopia - Patient consent to undergo keratorefractive correction of myopia Exclusion Criteria: - Pregnant or lactating women

Additional Information

Official title Use of the VisuMax Femtosecond Laser for the Correction of Myopia With Small Incision Lenticular Extraction
Description Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital. The patients will be followed with standard clinical techniques (slit-lamp examination, refraction, topography) during their normal follow-up up to 12 months after treatment.
Trial information was received from ClinicalTrials.gov and was last updated in May 2015.
Information provided to ClinicalTrials.gov by University of Aarhus.